%0 Journal Article
%T Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
%A Menter A
%A Strober BE
%A Kaplan DH
%A Kivelevitch D
%A Prater EF
%A Stoff B
%A Armstrong AW
%A Connor C
%A Cordoro KM
%A Davis DMR
%A Elewski BE
%A Gelfand JM
%A Gordon KB
%A Gottlieb AB
%A Kavanaugh A
%A Kiselica M
%A Korman NJ
%A Kroshinsky D
%A Lebwohl M
%A Leonardi CL
%A Lichten J
%A Lim HW
%A Mehta NN
%A Paller AS
%A Parra SL
%A Pathy AL
%A Rupani RN
%A Siegel M
%A Wong EB
%A Wu JJ
%A Hariharan V
%A Elmets CA
%J J Am Acad Dermatol
%V 80
%N 4
%D Apr 2019
%M 30772098
%F 15.487
%R 10.1016/j.jaad.2018.11.057
%X Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations based on the available evidence. The treatment of psoriasis with biologic agents will be reviewed, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients regarding benefits as well as associated risks.